Evidence map›Paper›PMID 39320886›Full record

ArticleFuture oncology (London, England)2024

HER3 is widely expressed across diverse subtypes of NSCLC in a retrospective analysis of archived tissue samples.

Ross A Soo, Graham Clinthorne, Anu Santhanagopal, Chuntao Wu, Maha Karnoub, Parul Patel, Lukas Bubendorf

Abstract readClinical Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ross A SooNational University Hospital, Singapore, 119074, Singapore.ORCID 0000-0002-3053-3997
Graham ClinthorneDaiichi Sankyo, Basking Ridge, NJ 07920, USA.
Anu SanthanagopalBoehringer Ingelheim, Ridgefield, CT 06877, USA.
Chuntao WuDaiichi Sankyo, Basking Ridge, NJ 07920, USA.
Maha KarnoubDaiichi Sankyo, Basking Ridge, NJ 07920, USA.
Parul PatelDaiichi Sankyo, Basking Ridge, NJ 07920, USA.
Lukas BubendorfInstitute of Medical Genetics & Pathology, University Hospital Basel, 4031, Basel, Switzerland.

Funding

Daiichi Sankyo, Inc
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorCarcinoma, Non-Small-Cell LungImmunohistochemistryLung NeoplasmsReceptor, ErbB-3AdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesBiomarkers, TumorERBB3 protein, humanReceptor, ErbB-3EGFR mutationsgenomic alterationsHER3 expressionH-scorenon-small cell lung cancerPD-L1

Identifiers

PMID39320886
PMCPMC11572136

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.